BioPharmCatalyst Launches "Aiden," AI Chatbot for Biotech Investors
BioPharmCatalyst, a division of Scientist.com, has launched a new AI-powered chatbot named "Aiden" to deliver personalized customer service and support …
All Posts
The Promise of Chatbots in Clinical Trials
In the rapidly changing field of clinical trials, chatbots are becoming valuable tools for data analysis. These AI-driven conversational agents …
Proscia Releases Concentriq Embeddings and AI Toolkit for Digital Pathology Research
Proscia has introduced Concentriq Embeddings and the Proscia AI Toolkit as part of its Concentriq platform, providing technical resources for …
Even 10 Minutes Matter in Cancer Research
A recent study conducted by Indivumed Therapeutics highlights a crucial, yet often overlooked, factor in cancer research: the cold ischemia …
This Company Sets a New Milestone with World’s First Human Graphene Brain-Computer Interface
INBRAIN Neuroelectronics has announced the successful completion of the world’s first human procedure using their graphene-based brain-computer interface (BCI), a …
How Enterprise Architecture is Powering Digital Transformation in Healthcare
The healthcare industry is confronting critical challenges including a systemic labour shortage, rising costs (estimated to grow to its highest …
CluePoints Introduces Medical & Safety Review Tool to Optimize Clinical Data Management
CluePoints has launched the Medical & Safety Review (MSR) software, a new tool aimed at addressing inefficiencies in clinical data …
BioAge Labs Targets Obesity with Upsized IPO, Expected to Raise $198M to Fund Clinical Trials
BioAge Labs (Richmond, CA), a clinical-stage biopharmaceutical company developing therapies for metabolic diseases such as obesity, has announced the pricing …
Immunai and AstraZeneca Collaborate to Optimize Oncology Clinical Trials Using AI-driven Immune Mapping
Immunai, a New York-based AI biotech company, has entered a multi-year collaboration with AstraZeneca to optimize oncology clinical trials. This …
UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas
Laverock Therapeutics, a UK company based at the Stevenage Bioscience Catalyst, is advancing its programmable gene-silencing platform, GEiGS, aimed at …
Healthcare’s Cybersecurity Crisis: A Growing Threat Amid Outdated Technology
As healthcare systems embrace digital transformation, the increased reliance on connected devices, platforms, and remote work environments has significantly expanded …
Looking Back: How Etcembly's ETCh Study is Uncovering New Cancer Targets from Survivors
Despite advances in medical science, finding a cure for cancer remains an elusive goal. Currently, only half of all people …